Kaliamurthi, S.; Selvaraj, G.; Selvaraj, C.; Singh, S.K.; Wei, D.-Q.; Peslherbe, G.H.
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. Int. J. Mol. Sci. 2021, 22, 7071.
https://doi.org/10.3390/ijms22137071
AMA Style
Kaliamurthi S, Selvaraj G, Selvaraj C, Singh SK, Wei D-Q, Peslherbe GH.
Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. International Journal of Molecular Sciences. 2021; 22(13):7071.
https://doi.org/10.3390/ijms22137071
Chicago/Turabian Style
Kaliamurthi, Satyavani, Gurudeeban Selvaraj, Chandrabose Selvaraj, Sanjeev Kumar Singh, Dong-Qing Wei, and Gilles H. Peslherbe.
2021. "Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19" International Journal of Molecular Sciences 22, no. 13: 7071.
https://doi.org/10.3390/ijms22137071
APA Style
Kaliamurthi, S., Selvaraj, G., Selvaraj, C., Singh, S. K., Wei, D.-Q., & Peslherbe, G. H.
(2021). Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. International Journal of Molecular Sciences, 22(13), 7071.
https://doi.org/10.3390/ijms22137071